Navigation Links
TMC125 Showed Significant Virologic Response at Week 24 in,Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3,Trials

ents discontinued treatment for any reason vs. 73 in the placebo arm.

Most of the rashes seen with TMC125 were mild to moderate in severity, occurred within the first few weeks of treatment and resolved with continued TMC125 treatment. Grade 3 or 4 rash occurred in 1 percent of patients in the TMC125 arm and no patients in the placebo arm.

DUET-1 and -2 Study Design

The DUET studies are double-blind, placebo-controlled, international Phase 3 trials designed to assess the efficacy and safety of TMC125 in treatment- experienced adult HIV-1 patients with documented evidence of NNRTI and PI resistance. Participants were randomized to receive TMC125 200 mg twice daily or placebo, each given in addition to a BR.

In both studies, patient randomization was stratified for enfuvirtide use in the BR (no use, re-use, or first time use), previous darunavir use (used or not), and screening plasma viral load (<30,000 or >=30,000 copies per mL).

Patients with HIV-1 who were eligible for the DUET trials had a viral load of greater than 5,000 copies/mL, were on a stable antiretroviral therapy regimen, and had evidence of at least one NNRTI-resistance-associated mutation, either at screening or from historical resistance tests as well as evidence of three or more primary PI mutations at screening.

TMC125 Expanded Access Program

The expanded access program (EAP) for TMC125 is now open in a number of European countries, Canada and the United States. TMC125 is available to HIV-1 infected adults, at least 18 years old, who have limited treatment options either due to virological failure or intolerance to multiple ARV regimens. Patients must be three-class experienced, having received licensed treatment from each of the three major oral classes of anti-HIV drugs (NRTIs, NNRTIs, and PIs), unable to use currently approved NNRTIs due to resistance and/or intolerance and have received at least two PI-based regimens.

For more about the pro
'"/>




Page: 1 2 3 4

Related medicine technology :

1. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes
2. Late Breaking Data Released at ADA Showed that the Investigational Use of Januvia and Metformin as Initial Combination Therapy Provided Significant Glucose Lowering Efficacy over 54 Weeks in Patients with Type 2 Diabetes
3. Lumiracoxib Study Showed Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
4. Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B Showed Significant Reductions in Disease Activity in Patients with Active Systemic Lupus Erythematosus
5. Pivotal Phase III Trial Showed Promacta (eltrombopag olamine) Raised Platelet Counts and Reduced Bleeding in Patients With Chronic ITP
6. Pooled Studies Showed Desvenlafaxine Succinate Significantly Improved Painful Symptoms and Anxious Symptoms Associated with Major Depressive Disorder in Adults, Compared With Placebo
7. Treatment with Copaxone Plus Minocycline Showed Substantial Reduction of Disease Activity in Patients with Active Relapsing-Remitting Multiple Sclerosis
8. Treatment with Copaxone Plus Minocycline Showed Substantial Reduction of Disease Activity in Patients with Active Relapsing-Remitting Multiple Sclerosis
9. Laquinimod, a Novel Oral Compound, Showed Significant Reduction in Disease Activity in Patients with Relapsing-Remitting Multiple Sclerosis (RRMS)
10. OSI Pharmaceuticals Announces Pivotal Phase III Tarceva Study Published in the Journal of Clinical Oncology Showed Survival Improvement in Patients with Pancreatic Cancer
11. Data Published in Neurology Showed That Higher Dose of Copaxone Increased Efficacy in Relapsing-Remitting Multiple Sclerosis (RRMS)
Post Your Comments:
(Date:10/22/2014)... HOUSTON , Oct. 22, 2014  Charlene Vernak, RPh, ... York , recently was awarded the George Roentsch ... Vernak received the award in Houston ... The scholarship is awarded annually to an independent pharmacist ... nature of George Roentsch , a well-known pharmacist ...
(Date:10/22/2014)... A new report by Allied ... Form, End user, Application and Geography) - Size, Share, ... Opportunities, Segmentation and Forecast, 2013 - 2020", considers commercial ... key trends tracked, it is anticipated that the market ... 2020, registering a CAGR of 6.2% from 2014 to ...
(Date:10/22/2014)... LOUIS , Oct. 21, 2014  Early ... often subtle or unnoticed, but new technology, coupled ... outcomes and leading to earlier detection of eye ... affects 29 million Americans. If left untreated, these ... even blindness. Recently, optometric researchers ...
Breaking Medicine Technology:PCCA Awards Charlene Vernak, RPh, the George Roentsch Scholarship 2Global Disposable Gloves Market Expected to Grow to $7.9 Billion by 2020 - Allied Market Research 2Global Disposable Gloves Market Expected to Grow to $7.9 Billion by 2020 - Allied Market Research 3Global Disposable Gloves Market Expected to Grow to $7.9 Billion by 2020 - Allied Market Research 4Technology Advancements Enhance Early Detection of Eye Diseases Associated with Diabetes 2Technology Advancements Enhance Early Detection of Eye Diseases Associated with Diabetes 3
... 2010 ECRI Institute ... to improving patient care, has been awarded a multi-year ... Quality (AHRQ) to establish the first national Healthcare Horizon ... scanning is to provide a comprehensive, systematic, transparent process ...
... SANTA MONICA, Calif., Nov. 4, 2010 Reprints Desk, ... of Corporate Services Scott Ahlberg will highlight its "Mighty ... a session at the annual Pharma-Bio-Med Conference and ... Linkout Machine: The Article Resolver" will be held Tuesday, ...
Cached Medicine Technology:ECRI Institute Awarded AHRQ Contract to Establish National Healthcare Horizon Scanning System 2ECRI Institute Awarded AHRQ Contract to Establish National Healthcare Horizon Scanning System 3ECRI Institute Awarded AHRQ Contract to Establish National Healthcare Horizon Scanning System 4Reprints Desk to Highlight New Solution for Scientific, Technical, and Medical Research at Pharma-Bio-Med Conference and Exposition in Europe 2
(Date:10/22/2014)... (PRWEB) October 22, 2014 On Saturday, October ... its fourth annual family health and fitness fair ¡Vive tu ... physical activity and good nutrition for better health and wellness ... which is free and open to the public, will be ... Brownsville, from 9:00 am to 1:00 pm. , “¡Vive ...
(Date:10/22/2014)... October 22, 2014 Medical ... company, is happy to announce that our co-founder ... Staffing Industry Analysts’ Staffing 100 for 2014. Anderson ... “100 most influential people in the staffing industry,” ... Solutions, the 13th-largest healthcare staffing company in the ...
(Date:10/22/2014)... For Dr. Iris Hunter, a job is more than ... her life’s mission. Her extensive experience in the nonprofit sector, ... HomeCare, make it clear that Hunter’s mission is to serve ... makes a difference in the lives of others,” Hunter said. ... research, I felt ready to start on this journey as ...
(Date:10/22/2014)... The United States is now mandating that all ... Africa land at one of five airports equipped ... In a statement released Tuesday, Homeland Security ... air passengers from Guinea, Liberia and Sierra Leone ... -- New York City,s Kennedy International Airport, Washington ...
(Date:10/22/2014)... 2014 The Louis W. ... dedicated to distribute health information technology innovation to ... announced the development of six key guiding principles ... receiving healthcare. These are an expansion of the ... care that is respectful of and responsive to ...
Breaking Medicine News(10 mins):Health News:Brownsville Community Health Center Presents Fourth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 2Health News:Brownsville Community Health Center Presents Fourth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 3Health News:Brownsville Community Health Center Presents Fourth Annual ¡Vive Tu Vida! Get Up! Get Moving!® Event 4Health News:Medical Solutions Co-Founder/CFO Scott Anderson Named to Staffing Industry Analysts’ 2014 Staffing 100 2Health News:Medical Solutions Co-Founder/CFO Scott Anderson Named to Staffing Industry Analysts’ 2014 Staffing 100 3Health News:Dr. Iris Hunter to Host Grand Opening of FirstLight HomeCare Tomorrow 2Health News:Passengers From Ebola-Affected Countries Must Land at Designated U.S. Airports 2Health News:Passengers From Ebola-Affected Countries Must Land at Designated U.S. Airports 3Health News:The Sullivan Institute for Healthcare Innovation Announces Release of Guiding Principles for Patient Experience-Centered Care 2
... with heart disease should take special precautions before ... to reduce their risk of a cardiac event, ... College of Cardiology and the American Heart Association., ... Guidelines on Perioperative Cardiovascular Evaluation and Care for ...
... Wyeth (NYSE: WYE ),announced today the election of ... October 1, 2007. This election increases the number,of Wyeth board ... and Chief Executive Officer of International,Flavors & Fragrances Inc. (NYSE: ... world,s,leading creators of flavors and fragrances used in a wide ...
... ,Bad Public Policy, WASHINGTON, Sept. 27 - ... Western Reserve University professors Max,Mehlman and Dale Nance ... and would come at the expense of injured ... from the American Association for,Justice Robert L. Habush ...
... October,4 in San Diego Informs Teachers, Administrators on how to Identify and ... ... Educators are in a unique,position to save lives when they know ... this reason, the National Eating Disorders Association will host an,Educators Seminar on ...
... October 3, 2007, CHAPEL HILL, N.C., Sept. 27 ... will join thousands across the,world who are making the ... school on International Walk to School Day. "We,re ... Walk to School Day events as catalysts to getting ...
... by 100 million years , THURSDAY, Sept. 27 (HealthDay ... in Earth,s atmosphere 50 million to 100 million years ... teams reporting in the Sept. 28 issue of the ... atmospheric oxygen levels increased sharply from very low levels ...
Cached Medicine News:Health News:Guidelines help patients reduce risk of cardiac event before surgery 2Health News:Guidelines help patients reduce risk of cardiac event before surgery 3Health News:New Report Says 'Health Courts' Bureaucracies Offer Big Financial Burdens and Loss of Patient Rights 2Health News:Spectrum of Eating Disorders - from Anorexia to Obesity - are Cause for Rising Concern among K-12 Students and Educators 2Health News:Children Around the Globe Walk Toward a Lifetime of Healthy Habits 2Health News:Earth's Oxygen May Have Arrived Earlier 2
... The Elbow Cryo/Cuff combines the therapeutic benefits ... swelling, and cold to minimize pain. The ... the elbow providing maximum cryotherapy. The Elbow ... in addition to a pediatric size.,All Cryo/Cuffs ...
... the Pneumatic Armband to focus compression where ... the Armband concentrates compression directly on the ... more support and less constriction. Designed for ... to conform to the arm's tapered contour ...
... The Bledsoe Original Arm Brace is ... elbow strains and ligament trauma. The Bledsoe ... limited R.O.M. or locked control of the ... Bledsoe Extender Arm Brace can be formed, ...
... fits almost any arm -- simply bend the ... exact requirements. The cuffs are connected by an ... almost any elbow angle. The central part of ... contacts the elbow joint.,Special attention is paid to ...
Medicine Products: